BG100476A - Съединения за медицинска употреба - Google Patents
Съединения за медицинска употреба Download PDFInfo
- Publication number
- BG100476A BG100476A BG100476A BG10047696A BG100476A BG 100476 A BG100476 A BG 100476A BG 100476 A BG100476 A BG 100476A BG 10047696 A BG10047696 A BG 10047696A BG 100476 A BG100476 A BG 100476A
- Authority
- BG
- Bulgaria
- Prior art keywords
- acetyl
- alanyl
- glucosaminyl
- acetylmuramyl
- cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Silicon Compounds (AREA)
- Silicon Polymers (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939320820A GB9320820D0 (en) | 1993-10-08 | 1993-10-08 | Compounds for medicinal use |
| PCT/GB1994/002167 WO1995010293A1 (fr) | 1993-10-08 | 1994-10-05 | Composes a usage medicinal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG100476A true BG100476A (bg) | 1996-12-31 |
Family
ID=10743251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG100476A BG100476A (bg) | 1993-10-08 | 1996-04-03 | Съединения за медицинска употреба |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5877147A (fr) |
| EP (1) | EP0722332B1 (fr) |
| JP (1) | JP3954644B2 (fr) |
| KR (1) | KR100337977B1 (fr) |
| AT (1) | ATE183397T1 (fr) |
| AU (1) | AU680302B2 (fr) |
| BG (1) | BG100476A (fr) |
| CA (1) | CA2173322A1 (fr) |
| CZ (1) | CZ99796A3 (fr) |
| DE (1) | DE69420145T2 (fr) |
| GB (1) | GB9320820D0 (fr) |
| HU (1) | HUT75530A (fr) |
| IL (1) | IL111198A0 (fr) |
| LV (1) | LV11595B (fr) |
| SK (1) | SK42396A3 (fr) |
| WO (1) | WO1995010293A1 (fr) |
| ZA (1) | ZA947894B (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9413935D0 (en) * | 1994-07-11 | 1994-08-31 | Peptech Uk Ltd | Use of maramyl peptide compounds |
| WO1997005889A1 (fr) * | 1995-08-03 | 1997-02-20 | Slesarev Vladimir I | Vaccination non specifique par des composes contenant un acide amine de type d |
| NL1014380C2 (nl) * | 2000-02-14 | 2001-08-15 | Friesland Brands Bv | Darmwandversterkend voedingsmiddel. |
| ATE545433T1 (de) * | 2000-05-10 | 2012-03-15 | Signe Biopharma Inc | Mittel und methoden zur demonstration der sekretorischen immunsystem-regulierung von auf steroid hormon reagierende krebszellen |
| US7863011B2 (en) * | 2000-05-10 | 2011-01-04 | Signe Biopharma, Inc. | Screening method for predicting susceptibility to breast cancer |
| US6867238B2 (en) * | 2001-06-22 | 2005-03-15 | Gerhard N. Schrauzer | Compositions for the treatment and prevention of cancer |
| US7425331B2 (en) * | 2002-04-10 | 2008-09-16 | Protalex, Inc. | Protein A methods of use |
| US7211258B2 (en) * | 2002-04-10 | 2007-05-01 | Protalex, Inc. | Protein A compositions and methods of use |
| US7112564B2 (en) * | 2003-04-09 | 2006-09-26 | Zylacta Corporation | Biodegradable glucosaminemuramyl peptides for apoptosis modulation |
| WO2005007676A2 (fr) * | 2003-07-10 | 2005-01-27 | Rajadhyaksha V J | Glycopeptides pour le traitement de la sla et d'autres troubles metaboliques et autoimmuns |
| US8163702B2 (en) * | 2006-04-20 | 2012-04-24 | Sciclone Pharmaceuticals, Inc. | Treatment of melanoma |
| UA96980C2 (ru) * | 2007-02-13 | 2011-12-26 | Сайклон Фармасютикалс, Инк. | Способ уменьшения степени ухудшения состояния, поражения или повреждения слизистой оболочки |
| AU2009232504B2 (en) | 2008-04-01 | 2013-04-04 | Innate Immunotherapeutics Limited | Compositions and methods for treatment of neoplastic disease |
| NZ571665A (en) * | 2008-09-30 | 2011-01-28 | Innate Therapeutics Ltd | Compositions and methods for treatment of radiation exposure utilising cross-linked muramyl dipeptide microparticles |
| RU2571551C1 (ru) * | 2015-04-16 | 2015-12-20 | Закрытое акционерное общество "ПЕПТЕК" | Специфическая сочетанная терапия злокачественных опухолей цитостатиком и его модификатором |
| JP2024511067A (ja) | 2021-03-19 | 2024-03-12 | トレインド セラピューティクス ディスカバリー，インコーポレーテッド | 訓練された免疫を調節するための化合物およびその使用方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4186194A (en) * | 1973-10-23 | 1980-01-29 | Agence Nationale De Valorisation De La Recherche (Anvar) | Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents |
| US4370265A (en) * | 1974-10-22 | 1983-01-25 | Agence Nationale De Valorisation | Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents |
| GB1563561A (en) * | 1976-06-23 | 1980-03-26 | Daiichi Seiyaku Co | Muramyldipeptide derivatives and process for the preparation thereof |
| SU727647A1 (ru) * | 1977-11-02 | 1980-04-15 | Институт биоорганической химии им.М.М.Шемякина | Гликопептиды,обладающие противоопухолевой активностью и способ их получени |
| JPS6033120B2 (ja) * | 1977-11-15 | 1985-08-01 | 第一製薬株式会社 | 新規ムラミルジペプチド誘導体 |
| EP0002677B1 (fr) * | 1977-12-02 | 1982-10-13 | Takeda Chemical Industries, Ltd. | Dérivés de glucosamine-peptides et leurs compositions pharmaceutiques |
| FR2428050A1 (fr) * | 1978-06-05 | 1980-01-04 | Anvar | Oligomeres de composes du type muramyl-peptide et medicaments les contenant |
| JPS5519236A (en) * | 1978-07-27 | 1980-02-09 | Dai Ichi Seiyaku Co Ltd | Muramyl dipeptide derivative |
| JPS5618996A (en) * | 1979-06-21 | 1981-02-23 | Dai Ichi Seiyaku Co Ltd | Muramyldipeptide derivative |
| FI75578C (fi) * | 1979-07-25 | 1988-07-11 | Ciba Geigy Ag | Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider. |
| US5189014A (en) * | 1979-12-03 | 1993-02-23 | Cowan Jr Fred M | Method of treating cellular Fc receptor mediated hypersensitivity immune disorders |
| US4684625A (en) * | 1982-07-08 | 1987-08-04 | Syntex (U.S.A.) Inc. | Method for enhancing the anti-infective activity of muramyldipeptide derivatives |
| US4522811A (en) * | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4774085A (en) * | 1985-07-09 | 1988-09-27 | 501 Board of Regents, Univ. of Texas | Pharmaceutical administration systems containing a mixture of immunomodulators |
| US4774058A (en) * | 1985-09-26 | 1988-09-27 | Mehl Ehrenfried L | Apparatus for, and methods of, operating upon a fluid |
| HU205147B (en) * | 1989-06-29 | 1992-03-30 | Sandoz Ag | Process for producing muramyl dipeptide derivative and pharmaceutical compostions comprising same |
| EP0615522B1 (fr) * | 1991-11-19 | 1999-09-22 | Peptech (Uk) Limited | Composes de muramyl utilises dans le traitement de choc septique |
-
1993
- 1993-10-08 GB GB939320820A patent/GB9320820D0/en active Pending
-
1994
- 1994-10-05 AU AU77890/94A patent/AU680302B2/en not_active Ceased
- 1994-10-05 US US08/624,592 patent/US5877147A/en not_active Expired - Fee Related
- 1994-10-05 CA CA002173322A patent/CA2173322A1/fr not_active Abandoned
- 1994-10-05 JP JP51143795A patent/JP3954644B2/ja not_active Expired - Fee Related
- 1994-10-05 WO PCT/GB1994/002167 patent/WO1995010293A1/fr not_active Application Discontinuation
- 1994-10-05 HU HU9600887A patent/HUT75530A/hu unknown
- 1994-10-05 KR KR1019960701835A patent/KR100337977B1/ko not_active IP Right Cessation
- 1994-10-05 AT AT94928469T patent/ATE183397T1/de active
- 1994-10-05 CZ CZ96997A patent/CZ99796A3/cs unknown
- 1994-10-05 EP EP94928469A patent/EP0722332B1/fr not_active Expired - Lifetime
- 1994-10-05 DE DE69420145T patent/DE69420145T2/de not_active Expired - Lifetime
- 1994-10-05 SK SK423-96A patent/SK42396A3/sk unknown
- 1994-10-07 ZA ZA947894A patent/ZA947894B/xx unknown
- 1994-10-07 IL IL11119894A patent/IL111198A0/xx unknown
-
1996
- 1996-04-03 BG BG100476A patent/BG100476A/bg unknown
- 1996-04-08 LV LVP-96-98A patent/LV11595B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2173322A1 (fr) | 1995-04-20 |
| SK42396A3 (en) | 1997-01-08 |
| KR100337977B1 (ko) | 2002-10-09 |
| LV11595A (en) | 1996-12-20 |
| HU9600887D0 (en) | 1996-06-28 |
| ATE183397T1 (de) | 1999-09-15 |
| IL111198A0 (en) | 1995-12-08 |
| US5877147A (en) | 1999-03-02 |
| JP3954644B2 (ja) | 2007-08-08 |
| AU680302B2 (en) | 1997-07-24 |
| EP0722332A1 (fr) | 1996-07-24 |
| DE69420145D1 (de) | 1999-09-23 |
| ZA947894B (en) | 1996-04-09 |
| DE69420145T2 (de) | 1999-12-09 |
| JPH09503776A (ja) | 1997-04-15 |
| WO1995010293A1 (fr) | 1995-04-20 |
| HUT75530A (en) | 1997-05-28 |
| LV11595B (en) | 1997-06-20 |
| EP0722332B1 (fr) | 1999-08-18 |
| CZ99796A3 (en) | 1996-09-11 |
| AU7789094A (en) | 1995-05-04 |
| GB9320820D0 (en) | 1993-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG100476A (bg) | Съединения за медицинска употреба | |
| EP0614369B1 (fr) | Compositions pharmaceutiques dipeptidiques et leurs procedes d'utilisation | |
| US6139862A (en) | Pharmaceutical dipeptide compositions and methods of use thereof | |
| AU2010220800B2 (en) | Method for preventing and treating hyperpermeability | |
| EP0615522B1 (fr) | Composes de muramyl utilises dans le traitement de choc septique | |
| AU668088B2 (en) | Pharmaceutical dipeptide compositions and methods of use thereof | |
| CA2194678A1 (fr) | Utilisation de composes peptidiques de muramyle | |
| CZ86197A3 (en) | Use of muramyl peptide compounds | |
| CN1265799C (zh) | 含锌化合物和谷氨酰胺类的组合物 | |
| WO2008003013A2 (fr) | Médicaments antitumorigènes combinés contenant un inhibiteur hdac et un peptidomimétique tsp-1 | |
| WO1998009989A1 (fr) | Emploi de peptides du type muramylpeptides pour le traitement de troubles de myelosuppression ou d'autres etats affectant l'immunite | |
| FR2477551A1 (fr) | Nouveaux derives de l'a, a'-trehalose et medicaments les contenant | |
| WO1999003504A1 (fr) | Compositions medicamenteuses destinees au traitement des maladies immunodeficitaires | |
| RU96109376A (ru) | Соединения для применения в медицине | |
| WO2006105317A2 (fr) | Combinaison de médicaments antitumorigènes et programme de dosage | |
| JPH08157371A (ja) | 腫瘍肝転移抑制剤 |